MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients
Autor: | Raquel Ferrer-Lorente, Mario Ezquerra, María-José Martí, Manel Fernández, Teresa Botta-Orfila, Carles Calatayud, Rubén Fernández-Santiago, Xavier Morató, Antonella Consiglio, Eduard Tolosa, Angel Raya, Carles Gaig |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male 0301 basic medicine Aging Induced Pluripotent Stem Cells Down-Regulation Gene Expression Biology Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 microRNA (miRNA) 03 medical and health sciences Parkinson disease (PD) Neural Stem Cells Downregulation and upregulation Dopaminergic neuron (DAn) microRNA Humans Epigenetics Induced pluripotent stem cell Transcription factor Aged Transcription factor (TF) Dopaminergic Neurons Gene Expression Profiling General Neuroscience Dopaminergic Cell Differentiation Parkinson Disease Middle Aged Up-Regulation Dopaminergic neuron (DAn) Leucine-rich repeat kinase 2 (LRRK2) Parkinson disease (PD) Transcription factor (TF) microRNA (miRNA) MicroRNAs Leucine-rich repeat kinase 2 (LRRK2) Female 030104 developmental biology Cancer research Neurology (clinical) Geriatrics and Gerontology FOXA1 Reprogramming Developmental Biology |
Zdroj: | NEUROBIOLOGY OF AGING r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu Fundació Sant Joan de Déu r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname |
ISSN: | 0197-4580 |
DOI: | 10.1016/j.neurobiolaging.2018.05.032 |
Popis: | MicroRNA (miRNA) misregulation in peripheral blood has been linked to Parkinson disease (PD) but its role in the disease progression remains elusive. We performed an explorative genome-wide study of miRNA expression levels in dopaminergic neurons (DAn) from PD patients generated by somatic cell reprogramming and induced pluripotent stem cells differentiation. We quantified expression levels of 377 miRNAs in DAn from 3 sporadic PD patients (sPD), 3 leucine-rich repeat kinase 2-associated PD patients (L2PD) (total 6 PD), and 4 healthy controls. We identified differential expression of 10 miRNA of which 5 were upregulated in PD (miR-9-5p, miR-135a-5p, miR-135b-5p, miR-449a, and miR-449b-5p) and 5 downregulated (miR-141-3p, miR-199a-5p, miR-299-5p, miR-518e-3p, and miR-519a-3p). Changes were similar in sPD and L2PD. Integrative analysis revealed significant correlations between miRNA/mRNA expression. Moreover, upregulation of miR-9-5p and miR-135b-5p was associated with downregulation of transcription factors related to the DNA hypermethylation of enhancer elements in PD DAn (FOXA1 and NR3C1). In summary, miRNA changes are associated with monogenic L2PD and sPD and co-occur with epigenetic changes in DAn from PD patients. |
Databáze: | OpenAIRE |
Externí odkaz: |